Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

Stijn P. Andeweg; Brechje de Gier; Dirk Eggink; Caroline van den Ende; Noortje van Maarseveen; Lubna Ali; Boris Vlaemynck; Raf Schepers; Susan J. M. Hahné; Chantal B. E. M. Reusken; Hester E. de Melker; Susan van den Hof; Mirjam J. Knol

doi:10.1038/s41467-022-31838-8

Nature Communications (Aug 2022)

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

Stijn P. Andeweg,
Brechje de Gier,
Dirk Eggink,
Caroline van den Ende,
Noortje van Maarseveen,
Lubna Ali,
Boris Vlaemynck,
Raf Schepers,
Susan J. M. Hahné,
Chantal B. E. M. Reusken,
Hester E. de Melker,
Susan van den Hof,
Mirjam J. Knol

Affiliations

Stijn P. Andeweg: Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)
Brechje de Gier: Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)
Dirk Eggink: Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)
Caroline van den Ende: Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)
Noortje van Maarseveen: Saltro Diagnostic Center for Primary Care
Lubna Ali: Saltro Diagnostic Center for Primary Care
Boris Vlaemynck: SYNLAB
Raf Schepers: SYNLAB
Susan J. M. Hahné: Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)
Chantal B. E. M. Reusken: Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)
Hester E. de Melker: Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)
Susan van den Hof: Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)
Mirjam J. Knol: Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)

DOI: https://doi.org/10.1038/s41467-022-31838-8
Journal volume & issue: Vol. 13, no. 1
pp. 1 – 9

Abstract

Read online

The protection of COVID-19 vaccines against emerging variants needs to be monitored. Here, the authors use community testing data from the Netherlands and find that protection against infection by Omicron subvariants BA.1 and 2 is low and that booster vaccines considerably but temporarily increase protection.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal